These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24808662)

  • 1. Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac.
    Dasankoppa FS; Ningangowdar M; Sholapur H
    J Basic Clin Pharm; 2012 Dec; 4(1):2-9. PubMed ID: 24808662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin.
    Kanagale P; Lohray BB; Misra A; Davadra P; Kini R
    AAPS PharmSciTech; 2007 Jul; 8(3):E53. PubMed ID: 17915803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combination.
    Kumaravelrajan R; Narayanan N; Suba V
    Lipids Health Dis; 2011 Apr; 10():51. PubMed ID: 21477386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and development of controlled porosity osmotic tablet of diltiazem hydrochloride.
    Shahi SR; Zadbuke NS; Gulecha B; Shivanikar SS; Shinde SB
    J Adv Pharm Technol Res; 2012 Oct; 3(4):229-36. PubMed ID: 23378944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of oral osmotic pump of butorphanol tartrate.
    Shah B; Raichandani Y; Misra A
    Pharm Dev Technol; 2014 Nov; 19(7):868-80. PubMed ID: 24079361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
    Thakkar HP; Pancholi N; Patel CV
    AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of osmotically controlled oral drug delivery system of glipizide.
    Verma RK; Garg S
    Eur J Pharm Biopharm; 2004 May; 57(3):513-25. PubMed ID: 15093601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane.
    Makhija SN; Vavia PR
    J Control Release; 2003 Apr; 89(1):5-18. PubMed ID: 12695059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon targeted delivery systems of metronidazole based on osmotic technology: development and evaluation.
    Kumar P; Singh S; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Sep; 56(9):1234-42. PubMed ID: 18758093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of push-pull based osmotic delivery system for pramipexole.
    Wakode R; Bhanushali R; Bajaj A
    PDA J Pharm Sci Technol; 2008; 62(1):22-31. PubMed ID: 18402365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of buspirone oral osmotic pump tablet.
    Derakhshandeh K; Berenji MG
    Res Pharm Sci; 2014; 9(4):233-41. PubMed ID: 25657794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, evaluation, and influence of formulation and process variables on
    Arjun N; Narendar D; Sunitha K; Harika K; Nagaraj B
    Int J Pharm Investig; 2016; 6(4):238-246. PubMed ID: 28123994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Characterization of an Osmotic Pump System for Optimal Feeding and pH Control in
    Abedin S; Ranjbari J; Haeri A; Vahidi H; Moghimi HR
    Iran J Pharm Res; 2024; 23(1):e138677. PubMed ID: 39005735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.
    Shokri J; H Zarrintan M; Ghanbarzadeh S; Arash Z; Farahani A; Adibkia K
    Drug Res (Stuttg); 2013 Aug; 63(8):414-9. PubMed ID: 23599037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
    Patel KN; Mehta TA
    PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled porosity osmotic pumps of highly aqueous soluble drug containing hydrophilic polymers as release retardants.
    Prabakaran D; Singh P; Kanaujia P; Mishra V; Jaganathan KS; Vyas SP
    Pharm Dev Technol; 2004 Nov; 9(4):435-42. PubMed ID: 15581079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of microporous osmotic tablets of diltiazem hydrochloride.
    Bathool A; Gowda DV; Khan MS; Ahmed A; Vasudha SL; Rohitash K
    J Adv Pharm Technol Res; 2012 Apr; 3(2):124-9. PubMed ID: 22837961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.
    Adibkia K; Ghanbarzadeh S; Shokri MH; Arami Z; Arash Z; Shokri J
    Pharm Dev Technol; 2014 Jun; 19(4):507-12. PubMed ID: 23763379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-suspension coating as a technique to modulate the drug release from controlled porosity osmotic pumps for a soluble agent.
    Bahari LA; Javadzadeh Y; Jalali MB; Johari P; Nokhodchi A; Shokri J
    Colloids Surf B Biointerfaces; 2017 May; 153():27-33. PubMed ID: 28208062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.